ConductScience.org, home

Paper237402

Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.

Regårdh CG. Acta Pharmacol Toxicol (Copenh), 1975. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol. Papers, record 237402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/237402

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics and biopharmaceutics of some adrenergic beta-receptor antagonists with special emphasis on alprenolol and metoprolol.
PubMed
Journal
Acta Pharmacol Toxicol (Copenh)
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2019-08-27
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Regårdh CGC G

Source PubMed

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adrenergic beta-AntagonistsMajor topic
AlprenololMajor topic
PropanolaminesMajor topic
Biological Availability
Biopharmaceutics
Biotransformation
Blood Pressure
Half-Life
Heart Rate
Humans
Kidney
Kinetics
Phenyl Ethers
Physical Exertion
Time Factors

Source PubMed

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
27,520,107Effect of catecholamines and β-blockers on linoleic acid desaturation activity.Lipids1978https://conductscience.org/library/papers/27520107PubMed
26,403,702Perspectives on the history and scientific contributions of Gerhard Levy.J Pharmacokinet Pharmacodyn2015https://conductscience.org/library/papers/26403702PubMed
7,341,284Sotalol and metoprolol comparison of their anti-hypertensive effect.Eur J Clin Pharmacol1981https://conductscience.org/library/papers/7341284PubMed
6,150,103Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.J Pharmacokinet Biopharm1984https://conductscience.org/library/papers/6150103PubMed
6,102,500Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.Clin Pharmacokinet1980https://conductscience.org/library/papers/6102500PubMed
901,706Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect.Br J Clin Pharmacol1977https://conductscience.org/library/papers/901706PubMed
738,350Plasma timolol levels after oral and intravenous administration.Eur J Clin Pharmacol1978https://conductscience.org/library/papers/738350PubMed
13,958Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.Clin Pharmacokinet1976https://conductscience.org/library/papers/13958PubMed
11,985Hypertension: which beta-blocker?Drugs1976https://conductscience.org/library/papers/11985PubMed
6,243Clinical pharmacokinetics of beta-adrenoreceptors blockers.Drugs1976https://conductscience.org/library/papers/6243PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/237402

GET https://conductscience.org/api/papers/v1/237402/authors